INSURASALES

Tag: insurance

Top 3 Essential Insurance Policies for New U.S. Businesses in 2024

Explore the top three essential insurance policies new U.S. businesses need in 2024 to protect against cybercrime, employee liabilities, and property risks.

Natural Disaster Fraud Risks Escalate in Texas, Louisiana, and Florida

A study reveals high levels of scam activity targeting homeowners displaced by natural disasters in Texas, Louisiana, and Florida, highlighting challenges for insurers in fraud detection and claims management.

US Fertility Insurance Coverage Remains Patchy Amid Cost and Regulatory Challenges

Explore the fragmented landscape of US insurance coverage for IVF and fertility treatments, examining state mandates, cost barriers, and the impact of new California laws on health premiums and access.

Pennsylvania House Extends Prescription Assistance Protection for Seniors

Pennsylvania House unanimously approves bill to extend moratorium protecting seniors' eligibility for PACE and PACENET prescription drug programs through 2027.

Tariffs Could Boost U.S. Home Insurance Costs by $106 in 2025

Tariffs on imported construction materials could raise average U.S. home insurance premiums by $106 in 2025, driven by higher rebuilding costs and supply chain effects.

Rising Demand for Licensed, Insured Handypersons Highlights Risk Mitigation in Home Repairs

Explore the insurance implications and regulatory context of the expanding handyman and property maintenance market, emphasizing licensing, liability insurance, and consumer protection strategies for home repairs.

JAB Holding to Acquire Prosperity Life Group, Including Shenandoah Life, for $3.1B

JAB Holding plans a $3.1 billion acquisition of Prosperity Life Group, owner of Shenandoah Life Insurance, marking a significant move in the U.S. life insurance market pending Virginia regulatory approval.

Healthcare Sector Faces Mixed Market Trends Amid Insurer Losses and Pharma Gains

April 2025 market update reveals insurer stock declines amid UnitedHealth earnings miss, offset by pharma gains led by Eli Lilly's drug innovation and strong healthcare sector earnings projections.

U.S. Pharmaceutical Regulation and Pricing: April 2025 Update

April 2025 update on U.S. pharmaceutical regulation highlights executive orders, budget changes, CMS policies, IRA litigation, and 340B program developments shaping drug pricing and access.

Understanding Annuities: Types, Benefits, and Regulatory Oversight in Washington State

Explore the key types and benefits of annuities in Washington state, including fixed, variable, and equity-indexed options with regulatory details for insurance professionals.